Treatment and prognosis of heart failure with preserved ... - UpToDate
WEBAug 21, 2024 · Goals of therapy — For patients with HFpEF, the goals of treatment are to reduce HF symptoms, increase functional status, and reduce the risk of hospital admission. There is no clear evidence that pharmacologic therapy, diet, or other therapies reduce the risk of mortality in patients with HFpEF.
2023 ACC Expert Consensus on Management of HFpEF: Key Points
WEBApr 17, 2023 · Heart failure with preserved ejection fraction (HFpEF) is defined as signs and symptoms of HF with left ventricular EF (LVEF) ≥50%. Diagnosis and management of HFpEF needs multidisciplinary care involving primary care, cardiology, and HF specialists.
Pharmacologic Treatment For HFpEF: Role of Drug Therapies at …
WEBMar 8, 2022 · Renin-angiotensin aldosterone system inhibitors and sodium-glucose cotransport-2 inhibitors have emerged as promising drug therapies for reducing heart failure hospitalizations in HFpEF. To date, no medication classes have reduced cardiovascular or all-cause mortality in HFpEF.
2022 AHA/ACC/HFSA Guideline for the Management of Heart …
WEBApr 1, 2022 · Treatment of HFrEF Stages C and D. Colors correspond to COR in Table 2. Treatment recommendations for patients with HFrEF are displayed. Step 1 medications may be started simultaneously at initial (low) doses recommended for HFrEF.
Heart Failure With Preserved Ejection Fraction (HFpEF)
WEBMar 19, 2024 · The Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial was a randomized, double-blind trial of 3445 patients with symptomatic heart failure and an LVEF of greater than 45% that demonstrated some reduction in hospitalization rates for heart failure. This was particularly true for patients with an ...
2022 AHA/ACC/HFSA Guideline for the Management of Heart …
WEBApr 1, 2022 · The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients’ interests.
Heart failure with preserved ejection fraction - BMJ Best Practice
WEBMay 30, 2024 · Scoring systems (H₂FPEF and HFA-PEFF) are available to help discriminate HFpEF from other causes of dyspnoea. The goals of treatment are to reduce symptoms, reduce hospitalisations, and improve patients’ functional status.
Heart failure with preserved ejection fraction: everything the ...
WEBMar 16, 2024 · The core of therapeutic recommendations in HFpEF are focused on the treatment of underlying comorbidity and treating modifiable heart failure risk factors.
Heart failure with preserved ejection fraction: an update on ...
WEBJun 5, 2020 · HFpEF has no single guideline for diagnosis or treatment, the patient population is heterogeneously and inconsistently described, and longitudinal studies are lacking.
Medical Therapies for Heart Failure With Preserved Ejection Fraction
WEBDec 2, 2019 · There appears to be consensus to treat symptoms and risk factors for cardiovascular disease in patients with HFpEF, including antihypertensive treatment to achieve BP targets. 2–4 The lack of proven therapies that reduce clinical event rates in HFpEF constitutes a huge unmet public health need.